Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A New Exogenous Marker for Diagnosis of Oxidative Stress During Laproscopic Surgery

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2011 by Western Galilee Hospital-Nahariya.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
Migal, Galilee Technology Center
Information provided by:
Western Galilee Hospital-Nahariya
ClinicalTrials.gov Identifier:
NCT01393587
First received: July 12, 2011
Last updated: July 17, 2012
Last verified: July 2011

July 12, 2011
July 17, 2012
Not Provided
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT01393587 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
A New Exogenous Marker for Diagnosis of Oxidative Stress During Laproscopic Surgery
A New Exogenous Marker for Diagnosis of Oxidative Stress During Laproscopic Surgery

Recently, a new synthetic marker was developed, based on a molecule that is composed of Amino Acids and Linoleic Acid and Neucleic Acid, which is capable of detecting even minor changes of oxidative stress.

The investigators would like to assess the usefulness of this marker during positive pressure pneumoperitoneum, during laproscopic surgery, with or without intenstinal resection (ischemia induced by intra-abdominal pressure and vascualr compromise).

Not Provided
Interventional
Not Provided
Not Provided
  • Oxidative Stress
  • Laproscopy
Procedure: Taking blood samples
Experimental: Experimental
Intervention: Procedure: Taking blood samples
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • Healthy patients undergoing elective laproscopic cholecystectomy and patients undergoing operation for tumer of large intenstine.

Exclusion Criteria:

  • Patients suffering from Cardio Pulmonory and renal diseases
Both
18 Years and older
Yes
Contact: Amitai Bickel, Dr. +972-507887554 ext 7554 amitai@netvision.net.il
Contact: Y Mosenzon, M.A +972-49107011 ext 7022 yael.mosenzon@naharia.health.gov.il
Israel
 
NCT01393587
BIC-2011
Not Provided
Not Provided
Western Galilee Hospital-Nahariya
Migal, Galilee Technology Center
Not Provided
Western Galilee Hospital-Nahariya
July 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP